June 17, 2026

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN protein loss is associated...

recent articles

Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN...

Leica Biosystems: High-throughput Aperio GT Elite scanner with AI-enabled quality control supports digital and computational pathology workflows VISTA, CA – June 15, 2026 – Leica Biosystems, a Danaher company and a global leader in...

Join Aiforia for a webinar later this month. Pathologist and AI: A Collaboration in Practice Monday, June 29th, 2026 | 4:00 pm CEST | 5:00 pm EEST | 10:00 am EDT Register Now Even the most accurate AI models only fulfill their full...

Aiforia has been selected via a public tender, won by Palex, to provide AI-assisted diagnostic solutions to a regional health service provider in Spain. Aiforia Technologies Plc, Press Release, June 11, 2026 at 9:30 a.m. EEST Aiforia...

In medical school I drove a cab at night to make ends meet. I rented the medallion from a guy for $50 and kept the difference I made. The Army paid me $692 a month stipend on the Health Professions Scholarship and the studio apartment in...

[DEER PARK, Ill. — June 9, 2026] — Leica Biosystems, a Danaher company and a global leader in end to end anatomic and digital pathology solutions, is advancing how pharmaceutical organizations scale digital and computational pathology to...

OR

platinum partners

gold partners

Silver Partners

Media Partners